Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-02 @ 10:33 AM
Study NCT ID:
NCT02420795
Status:
TERMINATED
Last Update Posted:
2022-04-04
First Post:
2015-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Organization: